[ad_1]
The administration announced in August that a rollout plan was in place for the booster injections that would be initiated on September 20, but also clarified that the plan itself was pending FDA recommendations. Those eligible for a booster would be those who received their second dose eight months earlier. The latest guidelines from the FDA have led to some confusion as to whether a recall is necessary for everyone.
“It would surprise me if it did not become clear over the next few weeks that the administration of recalls may need to be expanded based on the data we’ve already seen in the United States and Israel,” Collins said.
Anthony Fauci, the head of the National Institute of Allergy and Infectious Diseases, also argued that the plan initially announced by the White House was in line with the advisory group’s recommendation. Ultimately, he believes the “right regimen” will include the original two injections plus a booster for everyone, although that may not be necessary at this time.
“You want to do it based on what the data is telling you, including the risk-benefit ratio, especially for young people who don’t typically have as severe a disease as the elderly and the rest,” said Fauci Sunday on NBC. Hurry. “” So I think there’s a good chance that as we go into the coming months, into the next year, you’ll see the data indicating the benefit of having a much broader coverage of people. “
Collins, on CBS’s “Face the Nation,” said the guidelines would continue to evolve. “This is how it should be. The science kind of happens in a very transparent way, looking at data from multiple places, our country, other countries and trying to make the best decision at the moment. This is what they did.
Speaking on ABC’s “This Week,” Fauci noted that all plans are subject to “continuous review” as data accumulates on Covid-19 and vaccines.
Collins and Fauci both largely pointed to data that suggests the effectiveness of the Pfizer vaccine is starting to wane, but the need for a booster would go to those most at risk first. Fauci also noted that data on Moderna – which has filed a recall request – and the Johnson & Johnson vaccines will continue to be submitted to the FDA for review.
A panel from the Centers for Disease Control and Prevention will meet this week to establish guidelines for administering the booster.
[ad_2]
Source link